RHO and neurodegenerative disease: MYO9A is an unconventional myosin responsible for the regulation of Rho GTPase activity within neurons, which in turn regulates neuronal morphology and function; for these reasons, the Rho family has been a recent therapeutic target for neurodegenerative diseases such as AD [29].